Liver and circulating NK1.1+CD3- cells are increased in infection with attenuated Salmonella typhimurium and are associated with reduced tumor in murine liver cancer

B. A. Feltis, J. S. Miller, David E Sahar, A. S. Kim, D. A. Saltzman, A. S. Leonard, C. L. Wells, T. D. Sielaff

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

An attenuated (ΔcyA, Δcrp) strain of Salmonella typhimurium (χ4550) containing a gene for human IL-2 (χ4550pIL2) reduces hepatic tumor burden when orally inoculated into mice with liver cancer; however, wild-type S. typhimurium is also associated with cancer regression. Therefore, experiments were designed to clarify the invasiveness and the anti-tumor properties of three strains of S. typhimurium. S. typhimurium χ4550pIL2, χ4550, or wild type (WT) was incubated with mature Caco-2 and HT-29 enterocytes, and S. typhimurium internalization was assessed. For infectivity experiments, mice were orally inoculated with saline or 109 S. typhimurium χ4550pIL2, χ4550, or WT; 48 h later mice were sacrificed for analysis of cecal bacteria and S. typhimurium translocation to mesenteric lymph nodes. For experiments involving tumor implantation, four groups were studied: saline control, tumor alone, χ4550pIL2+tumor, and χ4550+tumor. Mice were orally inoculated with saline or S. typhimurium and underwent laparotomy 24 h later with 5 × 104 MCA38 murine adenocarcinoma cells injected into the spleen. On day 14, liver tumors were counted and peripheral blood and hepatic lymphocyte populations were analyzed by FACScan. Attenuated S. typhimurium exhibited decreased internalization by cultured enterocytes and decreased infectivity after oral inoculation. Mice treated with χ4550pIL2 or χ4550 had fewer liver tumors and increased populations of hepatic and circulating NK1.1+CD3- lymphocytes compared to mice treated with saline (P < 0.01). These data suggest that attenuated S. typhimurium may have an application as an anti-tumor agent.

Original languageEnglish (US)
Pages (from-to)101-107
Number of pages7
JournalJournal of Surgical Research
Volume107
Issue number1
StatePublished - 2002
Externally publishedYes

Fingerprint

Salmonella typhimurium
Liver Neoplasms
Liver
Infection
Neoplasms
Enterocytes
Lymphocytes
Tumor Burden
Laparotomy
Population
Interleukin-2
Adenocarcinoma
Spleen
Lymph Nodes
Bacteria

ASJC Scopus subject areas

  • Surgery

Cite this

Liver and circulating NK1.1+CD3- cells are increased in infection with attenuated Salmonella typhimurium and are associated with reduced tumor in murine liver cancer. / Feltis, B. A.; Miller, J. S.; Sahar, David E; Kim, A. S.; Saltzman, D. A.; Leonard, A. S.; Wells, C. L.; Sielaff, T. D.

In: Journal of Surgical Research, Vol. 107, No. 1, 2002, p. 101-107.

Research output: Contribution to journalArticle

Feltis, B. A. ; Miller, J. S. ; Sahar, David E ; Kim, A. S. ; Saltzman, D. A. ; Leonard, A. S. ; Wells, C. L. ; Sielaff, T. D. / Liver and circulating NK1.1+CD3- cells are increased in infection with attenuated Salmonella typhimurium and are associated with reduced tumor in murine liver cancer. In: Journal of Surgical Research. 2002 ; Vol. 107, No. 1. pp. 101-107.
@article{bbe9ce90fa264217a7c73e88194a0c7e,
title = "Liver and circulating NK1.1+CD3- cells are increased in infection with attenuated Salmonella typhimurium and are associated with reduced tumor in murine liver cancer",
abstract = "An attenuated (ΔcyA, Δcrp) strain of Salmonella typhimurium (χ4550) containing a gene for human IL-2 (χ4550pIL2) reduces hepatic tumor burden when orally inoculated into mice with liver cancer; however, wild-type S. typhimurium is also associated with cancer regression. Therefore, experiments were designed to clarify the invasiveness and the anti-tumor properties of three strains of S. typhimurium. S. typhimurium χ4550pIL2, χ4550, or wild type (WT) was incubated with mature Caco-2 and HT-29 enterocytes, and S. typhimurium internalization was assessed. For infectivity experiments, mice were orally inoculated with saline or 109 S. typhimurium χ4550pIL2, χ4550, or WT; 48 h later mice were sacrificed for analysis of cecal bacteria and S. typhimurium translocation to mesenteric lymph nodes. For experiments involving tumor implantation, four groups were studied: saline control, tumor alone, χ4550pIL2+tumor, and χ4550+tumor. Mice were orally inoculated with saline or S. typhimurium and underwent laparotomy 24 h later with 5 × 104 MCA38 murine adenocarcinoma cells injected into the spleen. On day 14, liver tumors were counted and peripheral blood and hepatic lymphocyte populations were analyzed by FACScan. Attenuated S. typhimurium exhibited decreased internalization by cultured enterocytes and decreased infectivity after oral inoculation. Mice treated with χ4550pIL2 or χ4550 had fewer liver tumors and increased populations of hepatic and circulating NK1.1+CD3- lymphocytes compared to mice treated with saline (P < 0.01). These data suggest that attenuated S. typhimurium may have an application as an anti-tumor agent.",
author = "Feltis, {B. A.} and Miller, {J. S.} and Sahar, {David E} and Kim, {A. S.} and Saltzman, {D. A.} and Leonard, {A. S.} and Wells, {C. L.} and Sielaff, {T. D.}",
year = "2002",
language = "English (US)",
volume = "107",
pages = "101--107",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Liver and circulating NK1.1+CD3- cells are increased in infection with attenuated Salmonella typhimurium and are associated with reduced tumor in murine liver cancer

AU - Feltis, B. A.

AU - Miller, J. S.

AU - Sahar, David E

AU - Kim, A. S.

AU - Saltzman, D. A.

AU - Leonard, A. S.

AU - Wells, C. L.

AU - Sielaff, T. D.

PY - 2002

Y1 - 2002

N2 - An attenuated (ΔcyA, Δcrp) strain of Salmonella typhimurium (χ4550) containing a gene for human IL-2 (χ4550pIL2) reduces hepatic tumor burden when orally inoculated into mice with liver cancer; however, wild-type S. typhimurium is also associated with cancer regression. Therefore, experiments were designed to clarify the invasiveness and the anti-tumor properties of three strains of S. typhimurium. S. typhimurium χ4550pIL2, χ4550, or wild type (WT) was incubated with mature Caco-2 and HT-29 enterocytes, and S. typhimurium internalization was assessed. For infectivity experiments, mice were orally inoculated with saline or 109 S. typhimurium χ4550pIL2, χ4550, or WT; 48 h later mice were sacrificed for analysis of cecal bacteria and S. typhimurium translocation to mesenteric lymph nodes. For experiments involving tumor implantation, four groups were studied: saline control, tumor alone, χ4550pIL2+tumor, and χ4550+tumor. Mice were orally inoculated with saline or S. typhimurium and underwent laparotomy 24 h later with 5 × 104 MCA38 murine adenocarcinoma cells injected into the spleen. On day 14, liver tumors were counted and peripheral blood and hepatic lymphocyte populations were analyzed by FACScan. Attenuated S. typhimurium exhibited decreased internalization by cultured enterocytes and decreased infectivity after oral inoculation. Mice treated with χ4550pIL2 or χ4550 had fewer liver tumors and increased populations of hepatic and circulating NK1.1+CD3- lymphocytes compared to mice treated with saline (P < 0.01). These data suggest that attenuated S. typhimurium may have an application as an anti-tumor agent.

AB - An attenuated (ΔcyA, Δcrp) strain of Salmonella typhimurium (χ4550) containing a gene for human IL-2 (χ4550pIL2) reduces hepatic tumor burden when orally inoculated into mice with liver cancer; however, wild-type S. typhimurium is also associated with cancer regression. Therefore, experiments were designed to clarify the invasiveness and the anti-tumor properties of three strains of S. typhimurium. S. typhimurium χ4550pIL2, χ4550, or wild type (WT) was incubated with mature Caco-2 and HT-29 enterocytes, and S. typhimurium internalization was assessed. For infectivity experiments, mice were orally inoculated with saline or 109 S. typhimurium χ4550pIL2, χ4550, or WT; 48 h later mice were sacrificed for analysis of cecal bacteria and S. typhimurium translocation to mesenteric lymph nodes. For experiments involving tumor implantation, four groups were studied: saline control, tumor alone, χ4550pIL2+tumor, and χ4550+tumor. Mice were orally inoculated with saline or S. typhimurium and underwent laparotomy 24 h later with 5 × 104 MCA38 murine adenocarcinoma cells injected into the spleen. On day 14, liver tumors were counted and peripheral blood and hepatic lymphocyte populations were analyzed by FACScan. Attenuated S. typhimurium exhibited decreased internalization by cultured enterocytes and decreased infectivity after oral inoculation. Mice treated with χ4550pIL2 or χ4550 had fewer liver tumors and increased populations of hepatic and circulating NK1.1+CD3- lymphocytes compared to mice treated with saline (P < 0.01). These data suggest that attenuated S. typhimurium may have an application as an anti-tumor agent.

UR - http://www.scopus.com/inward/record.url?scp=0036403302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036403302&partnerID=8YFLogxK

M3 - Article

C2 - 12384070

AN - SCOPUS:0036403302

VL - 107

SP - 101

EP - 107

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 1

ER -